Personalising care in oesophageal cancer care with liquid biopsy.
Br J Cancer 2021;
125:1036-1038. [PMID:
33931744 DOI:
10.1038/s41416-021-01370-5]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2021] [Revised: 03/10/2021] [Accepted: 03/16/2021] [Indexed: 12/24/2022] Open
Abstract
The advent of ctDNA has the potential to be a game changer in some cancers, but limited data is available in oesophago-gastric cancers (OGC). The prognostic value of ctDNA and the potential for false positive results due to clonal haematopoiesis of indeterminate potential (CHIP) was recently reported in operable OGC.
Collapse